The bill seeks to modernize the Commonwealth's cannabis laws by establishing a Massachusetts Cannabis Control Commission and a Cannabis Advisory Board, which will consist of three commissioners appointed by the governor. The bill outlines the qualifications for these commissioners, their operational procedures, and ethical standards, including a prohibition on certain communications regarding investigations. It also repeals outdated sections of the General Laws and replaces the term "medical marijuana treatment center" with "medical marijuana establishment." Additionally, the bill introduces a new chapter on consumable CBD products, imposing a tax on their sale and requiring licenses for manufacturers, wholesalers, and retailers, while the Cannabis Advisory Board will provide recommendations on regulation and taxation.

Furthermore, the bill introduces regulations for the sale and manufacture of hemp beverage products and consumable CBD products, including age restrictions and an excise tax on hemp beverages. It mandates that manufacturers hold a specific endorsement from the commission and outlines penalties for non-compliance. The bill also amends definitions related to marijuana and hemp products, clarifying terms and establishing new definitions for various products. It requires the commission to conduct studies on cannabis use patterns and report findings by January 1, 2027, while also prioritizing applications from social equity businesses for retail licenses. Overall, the bill aims to enhance the regulatory framework for cannabis-related activities, ensuring safety, compliance, and accountability in the industry.

Statutes affected:
Bill Text: 62-2, 62C-66, 63-30, 64N-4, 94G-1, 94I-1, 128-116, 138-34C